Transcription of ESHAP and R-ESHAP
{{id}} {{{paragraph}}}
Example: bachelor of science
ESHAP and R-ESHAP
Lymphoma group This is a controlled document and therefore must not be changed or photocopied E-SHAP and R- ESHAP Authorised by Lymphoma Lead Prof Graham Collins Date: July 2022 Published: July 2022 Review date: July 2024 Version 1 of 6 ESHAP and R- ESHAP [This regimen can be delivered during an inpatient stay or can be used in ambulatory setting for patient(s) meeting the criteria. Refer to local Ambulatory Care Operational Policy] INDICATIONS LYMPHOMA [ICD-10 codes: , ] ESHAP : Chemo-sensitive relapsed / refractory Hodgkin lymphoma (Licensed indication (E), Off-label use (SHAP) / NHSE funded) R- ESHAP : Chemo-sensitive relapsed / refractory non-Hodgkin lymphoma (Licensed indication (R-EHA), Off-label use (SP) / NHSE funded) TREATMENT INTENT Disease modification PRE-ASSESSMENT 1.
2. Record stage of disease - contrast enhanced CT scan (neck, chest, abdomen and pelvis), ... In order to eliminate the risk of transmitting infective ... After 1-2 cycles with CT or PET-CT. Lymphoma group This is a controlled document and therefore must …
Loading..
Tags:
Information
Domain:
Source:
Link to this page:
Please notify us if you found a problem with this document: